ARTICLE | Distillery Therapeutics
DEGS1 inhibition for insulin resistance and hepatic steatosis
August 1, 2019 4:39 AM UTC
INDICATION: Diabetes; hepatic...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Diabetes; hepatic...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles